SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-002347
Filing Date
2017-04-05
Accepted
2017-04-05 09:05:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a2231692z424b5.htm 424B5 543325
2 G406692.JPG g406692.jpg GRAPHIC 20824
3 G6539.JPG g6539.jpg GRAPHIC 27287
4 G29931.JPG g29931.jpg GRAPHIC 13339
  Complete submission text file 0001047469-17-002347.txt   629504
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-212713 | Film No.: 17741218
SIC: 2836 Biological Products, (No Diagnostic Substances)